XML 41 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Restatement of Financial Statements - Summary of Impact of the Restatement (Details) - USD ($)
 1 Months Ended 3 Months Ended 4 Months Ended 6 Months Ended 7 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2019
Jun. 30, 2020
Dec. 31, 2019
Sep. 30, 2020
Dec. 31, 2020
Sep. 13, 2019
May 27, 2019
Warrant liabilities $ 13,085,000 $ 21,357,000 $ 17,661,000 $ 9,037,000 $ 13,085,000 $ 13,085,000 $ 17,661,000 $ 15,962,000 $ 21,357,000 $ 68,114,000 $ 11,370,000
Total liabilities 21,210,774 29,667,507 25,917,307 17,585,277 21,210,774 21,210,774 25,917,307 24,281,433 29,667,507 76,807,966 19,454,093  
Class A common stock subject to possible redemption 204,865,740 197,902,977 201,654,026 210,330,003 204,865,740 204,865,740 201,654,026 202,557,751 197,902,977 150,596,928 177,542,919  
Class A common stock                     225  
Addition paid-in capital 5,572,407 12,535,080 8,784,069 108,178 5,572,407 5,572,407 8,784,069 7,880,362 12,535,080 59,840,653 5,424,153  
Retained earnings (accumulated deficit) (573,356) (7,536,119) (3,785,070) 4,890,907 (573,356) (573,356) (3,785,070) (2,881,345) (7,536,119) (54,842,168) (424,952)  
Total stockholders' equity (deficit)   5,000,001 5,000,001 5,000,001     5,000,001 5,000,001 5,000,001 5,000,001 5,000,001
Change in fair value of warrant liabilities (4,514,000) (3,696,000) (8,624,000) 6,925,000 (176,000) (176,000) (1,699,000) (3,053,000) (5,395,000) (52,152,000)    
Issuance costs allocated to warrant liabilities         (484,024) (484,024)   (484,024)      
Other income (expense), net   (3,612,860) (8,535,862) 8,182,727 (454,604) (454,604) (353,135) (2,322,193) (3,965,995) (50,670,184)    
Net income (loss)   $ (3,751,049) $ (8,675,977) $ 7,772,252 $ (572,263) $ (573,356) $ (903,725) $ (2,881,345) $ (4,654,774) $ (51,960,823)    
Weighted average shares outstanding, basic and diluted   8,758,829 7,900,920 8,592,122 5,535,597 4,514,200 8,246,521 6,111,484 8,418,537 8,598,542    
Basic and diluted net loss per common share   $ (0.43) $ (1.10) $ 0.80 $ (0.13) $ 0.16 $ (0.22) $ (0.61) $ (0.66) $ (6.13)    
Change in value of shares subject to redemption           $ (88,179) $ (8,675,977) $ (2,396,159) $ (3,751,049) $ (51,960,823)    
Net cash used in operating activities           (692,713)   (904,969)   (862,597)    
Proceeds from sale of Units, net of underwriting discounts paid           225,884,024   225,884,024      
Net cash provided by financing activities           231,398,097   231,398,097      
Initial classification of ordinary shares subject to redemption           204,953,919   204,953,910      
Class A Common Stock [Member]                        
Class A common stock 375 $ 465 $ 427 $ 341 $ 375 375 427 409 465 941    
As Reported [Member]                        
Warrant liabilities        
Total liabilities 8,125,774 8,310,507 8,256,307 8,548,277 8,125,774 8,125,774 8,256,307 8,319,433 8,310,507 8,693,966 8,084,093  
Class A common stock subject to possible redemption 217,950,740 219,259,970 219,315,022 219,367,001 217,950,740 217,950,740 219,315,022 218,519,748 219,259,970 218,710,925    
Class A common stock                     111  
Addition paid-in capital 4,912,636 3,603,401 3,548,350 3,496,371 4,912,636 4,912,636 3,548,350 4,343,625 3,603,401 4,152,440 5,000,477  
Retained earnings (accumulated deficit) 86,668 1,395,905 1,450,954 1,502,931 86,668 86,668 1,450,954 655,679 1,395,905 846,856 (1,153)  
Total stockholders' equity (deficit)   5,000,008 5,000,005 5,000,003     5,000,005 5,000,004 5,000,008 5,000,004 5,000,010  
Change in fair value of warrant liabilities      
Issuance costs allocated to warrant liabilities                  
Other income (expense), net   83,140 88,138 1,257,727 205,420 205,420 1,345,865 1,214,831 1,429,005 1,481,816    
Net income (loss)   $ (55,049) $ (51,977) $ 847,252 $ 87,761 $ 86,668 $ 795,275 $ 655,679 $ 740,226 $ 191,177    
Weighted average shares outstanding, basic and diluted   70,007,989 70,005,122 7,003,637 5,307,098 5,274,301 7,004,380 6,075,732 5,307,098 7,008,667    
Basic and diluted net loss per common share   $ (0.01) $ (0.01) $ (0.01) $ (0.02) $ (0.02) $ (0.03) $ (0.04) $ (0.02) $ (0.12)    
Change in value of shares subject to redemption           $ 87,830 $ 795,274 $ 656,838 $ 740,222 $ 191,177    
Net cash used in operating activities           (208,689)   (420,945)        
Proceeds from sale of Units, net of underwriting discounts paid           225,400,000   225,400,000        
Net cash provided by financing activities           230,914,073   230,914,073        
Initial classification of ordinary shares subject to redemption           217,862,910   217,862,910        
As Reported [Member] | Class A Common Stock [Member]                        
Class A common stock subject to possible redemption                     188,912,910  
Class A common stock 122 $ 127 $ 126 $ 126 $ 122 122 126 125 127 133    
Adjustment [Member]                        
Warrant liabilities   21,357,000 17,661,000 9,037,000     17,661,000 15,962,000 21,357,000 68,114,000 11,370,000  
Total liabilities 13,085,000 21,357,000 17,661,000 9,037,000 13,085,000 13,085,000 17,661,000 15,962,000 21,357,000 68,114,000 11,370,000  
Class A common stock subject to possible redemption (13,085,000) (21,356,993) (17,660,996) (9,036,998) (13,085,000) (13,085,000) (17,660,996) (15,961,997) (21,356,993) (68,113,997)    
Class A common stock                     114  
Addition paid-in capital 659,771 8,931,679 5,235,719 (3,388,193) 659,771 659,771 5,235,719 3,536,737 8,931,679 55,688,213 423,676  
Retained earnings (accumulated deficit) (660,024) (8,932,024) (5,236,024) 3,387,976 (660,024) (660,024) (5,236,024) (3,537,024) (8,932,024) (55,689,024) (423,799)  
Total stockholders' equity (deficit)   (7) (4) (2)     (4) (3) (7) (3) (9)  
Change in fair value of warrant liabilities   (3,696,000) (8,624,000) 6,925,000 (176,000) (176,000) (1,699,000) (3,053,000) (5,395,000) (52,152,000)    
Issuance costs allocated to warrant liabilities         (484,024) (484,024)   (484,024)        
Other income (expense), net   (3,696,000) (8,624,000) 6,925,000 (660,024) (660,024) (1,699,000) (3,537,024) (5,395,000) (52,152,000)    
Net income (loss)   $ (3,696,000) $ (8,624,000) $ 6,925,000 $ (660,024) $ (660,024) $ (1,699,000) $ (3,537,024) $ (5,395,000) $ (52,152,000)    
Weighted average shares outstanding, basic and diluted   1,750,840 895,798 1,588,485 228,499 (760,101) 1,242,141 35,752 3,111,439 1,589,875    
Basic and diluted net loss per common share   $ (0.42) $ (1.09) $ 0.81 $ (0.11) $ (0.14) $ (0.19) $ (0.57) $ (0.64) $ (6.01)    
Change in value of shares subject to redemption           $ (176,009) $ (9,471,251) $ (3,052,997) $ (4,491,271) $ (52,152,000)    
Net cash used in operating activities           (484,024)   (484,024)        
Proceeds from sale of Units, net of underwriting discounts paid           484,024   484,024        
Net cash provided by financing activities           484,024   484,024        
Initial classification of ordinary shares subject to redemption           (12,908,991)   (12,909,000)        
Adjustment [Member] | Class A Common Stock [Member]                        
Class A common stock subject to possible redemption                     $ (11,369,991)  
Class A common stock $ 253 $ 338 $ 301 $ 215 $ 253 $ 253 $ 301 $ 284 $ 338 $ 808